ADT use was associated with a higher incidence of death from cardiovascular causes in men aged 65 years or older who were treated with EBRT, brachytherapy, or cryotherapy, but the difference did not reach statistical significance.
← all excerpts
Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer.
1
—
—